Discontinuation report KYNMOBI
Report ID | 191459 |
Drug Identification Number | 02500302 |
Brand name | KYNMOBI |
Common or Proper name | film soluble de chlorhydrate d'apomorphine |
Company Name | SUNOVION PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | APOMORPHINE HYDROCHLORIDE |
Strength(s) | 30MG |
Dosage form(s) | FILM, SOLUBLE |
Route of administration | SUBLINGUAL |
Packaging size | Cartons of 30 films |
ATC code | N04BC |
ATC description | |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2023-09-30 |
Actual discontinuation date | 2023-09-29 |
Remaining supply date | 2025-11-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | 7025 LANGER DRIVE, SUITE 301 MISSISSAUGA, ONTARIO CANADA L5N 0E8 |
Company contact information | Customer Service 1-888-363-0205 or csrsunovion@accuristix.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-05-02 | English | Compare |
v2 | 2023-05-02 | French | Compare |
v3 | 2023-05-02 | English | Compare |
v4 | 2023-05-02 | French | Compare |
v5 | 2023-10-02 | English | Compare |
v6 | 2023-10-02 | French | Compare |
v7 | 2023-11-17 | English | Compare |
Showing 1 to 7 of 7